在治疗梅博姆腺功能障碍时,基于光的设备的比较
Catarina Castro1, João Heitor Marques1, Ana Marta1
1Ophthalmology, Centro Hospitalar Universitário de Santo António, Porto, PRT.
Cureus
|August 7, 2023
概括
强脉冲光 (IPL) 有效地治疗长期的梅博米腺功能障碍 (MGD) 症状. 将IPL与低水平光疗 (LLLT) 结合起来,显示了对眼产生和腺功能的额外益处.
科学领域:
- 眼科医生 眼科 眼科
- 医疗器械 医疗器械
- 光疗法是一种照明疗法.
背景情况:
- 梅博米腺功能障碍 (MGD) 是一种常见的疾病,影响眼睛表面的健康.
- 各种基于光的疗法,包括强烈脉冲光 (IPL) 和低水平光疗法 (LLLT),正在探索MGD治疗.
研究的目的:
- 为了比较不同强烈脉冲光 (IPL) 设备的疗效,有或没有低水平光疗法 (LLLT),用于治疗梅博米腺功能障碍 (MGD).
主要方法:
- 一项前性观察性研究,涉及MGD患者.
- 三组接受了不同的IPL治疗:第一组 (IPL+LLLT),第二组 (IPL装置1) 和第三组 (IPL装置2).
- 评估包括眼睛表面疾病指数 (OSDI) 和眼睛表面在基线,3周和6个月的变化.
主要成果:
- 所有组在3周后都出现了症状改善 (OSDI);脂质层厚度 (LLT) 在1组和2组增加.
- 第1组在6个月后表现出基础流量增加和持续的OSDI和LLT改善.
- 仅IPL就减少了2组和3组的角膜染色,但3组在6个月后显示染色增加.
结论:
- IPL治疗为MGD患者提供长达六个月的持续症状缓解.
- 不同的IPL设备对眼睛表面参数具有不同的有益影响.
- 将LLLT添加到IPL治疗中可能会带来额外的长期益处,并积极影响眼腺功能.
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
Open Angle Glaucoma: Treatment
479
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
479


